164 related articles for article (PubMed ID: 32257207)
41. The TERT promoter mutation incidence is modified by germline TERT rs2736098 and rs2736100 polymorphisms in hepatocellular carcinoma.
Yuan X; Cheng G; Yu J; Zheng S; Sun C; Sun Q; Li K; Lin Z; Liu T; Li P; Xu Y; Kong F; Bjorkholm M; Xu D
Oncotarget; 2017 Apr; 8(14):23120-23129. PubMed ID: 28416747
[TBL] [Abstract][Full Text] [Related]
42. A functional promoter polymorphism in the TERT gene does not affect inherited susceptibility to breast cancer.
Varadi V; Brendle A; Grzybowska E; Johansson R; Enquist K; Butkiewicz D; Pamula-Pilat J; Pekala W; Hemminki K; Lenner P; Försti A
Cancer Genet Cytogenet; 2009 Apr; 190(2):71-4. PubMed ID: 19380022
[TBL] [Abstract][Full Text] [Related]
43. Telomerase reverse transcriptase promoter mutations in tumors originating from the adrenal gland and extra-adrenal paraganglia.
Papathomas TG; Oudijk L; Zwarthoff EC; Post E; Duijkers FA; van Noesel MM; Hofland LJ; Pollard PJ; Maher ER; Restuccia DF; Feelders RA; Franssen GJ; Timmers HJ; Sleijfer S; de Herder WW; de Krijger RR; Dinjens WN; Korpershoek E
Endocr Relat Cancer; 2014 Aug; 21(4):653-61. PubMed ID: 24951106
[TBL] [Abstract][Full Text] [Related]
44. Association of Telomerase Reverse Transcriptase Promoter Mutations with the Prognosis of Glioma Patients: a Meta-Analysis.
Wang X; Li X; Xu F; Zhang Y; Liu H; Tao Y
Mol Neurobiol; 2016 May; 53(4):2726-32. PubMed ID: 26351078
[TBL] [Abstract][Full Text] [Related]
45. Impacts of single nucleotide polymorphisms in three microRNAs (miR-146a, miR-196a2 and miR-499) on the susceptibility to cervical cancer among Indian women.
Thakur N; Singhal P; Mehrotra R; Bharadwaj M
Biosci Rep; 2019 Apr; 39(4):. PubMed ID: 30872409
[No Abstract] [Full Text] [Related]
46. TERT polymorphisms rs2853669 and rs7726159 influence on prostate cancer risk in Russian population.
Shadrina AS; Boyarskikh UA; Oskina NA; Sinkina TV; Lazarev AF; Petrova VD; Filipenko ML
Tumour Biol; 2015 Feb; 36(2):841-7. PubMed ID: 25296732
[TBL] [Abstract][Full Text] [Related]
47. Telomerase reverse transcriptase (TERT) rs2736100 polymorphism contributes to increased risk of glioma: evidence from a meta-analysis.
Peng Z; Tian D; Chen Q; Zhang S; Liu B; Ji B
Int J Clin Exp Med; 2015; 8(1):422-30. PubMed ID: 25785013
[TBL] [Abstract][Full Text] [Related]
48. TERT promoter hotspot mutations in breast cancer.
Shimoi T; Yoshida M; Kitamura Y; Yoshino T; Kawachi A; Shimomura A; Noguchi E; Yunokawa M; Yonemori K; Shimizu C; Kinoshita T; Ichimura K; Fukuda T; Fujiwara Y; Tamura K
Breast Cancer; 2018 May; 25(3):292-296. PubMed ID: 29222734
[TBL] [Abstract][Full Text] [Related]
49. Deciphering the Functions of Telomerase Reverse Transcriptase in Head and Neck Cancer.
Yeh TJ; Luo CW; Du JS; Huang CT; Wang MH; Chuang TM; Gau YC; Cho SF; Liu YC; Hsiao HH; Chen LT; Pan MR; Wang HC; Moi SH
Biomedicines; 2023 Feb; 11(3):. PubMed ID: 36979671
[TBL] [Abstract][Full Text] [Related]
50. Polymorphisms in human telomerase reverse transcriptase (hTERT) gene and susceptibility to gastric cancer in a Turkish population: Hospital-based case-control study.
Bayram S; Ülger Y; Sümbül AT; Kaya BY; Genç A; Rencüzoğullari E; Dadaş E
Gene; 2016 Jul; 585(1):84-92. PubMed ID: 27016301
[TBL] [Abstract][Full Text] [Related]
51. Association between
Tong Y; Xiang Y; Li B; Bao S; Zhou Y; Yuan W; Ling Y; Hao D; Zhu H; Sun Z
Cancer Cell Int; 2020; 20():313. PubMed ID: 32694935
[TBL] [Abstract][Full Text] [Related]
52. Telomerase reverse transcriptase mutations are independent predictor of disease-free survival in Middle Eastern papillary thyroid cancer.
Bu R; Siraj AK; Divya SP; Kong Y; Parvathareddy SK; Al-Rasheed M; Al-Obaisi KAS; Victoria IG; Al-Sobhi SS; Al-Dawish M; Al-Dayel F; Al-Kuraya KS
Int J Cancer; 2018 May; 142(10):2028-2039. PubMed ID: 29266240
[TBL] [Abstract][Full Text] [Related]
53. The associations of TERT-CLPTM1L variants and TERT mRNA expression with the prognosis of early stage non-small cell lung cancer.
Chen Z; Wang J; Bai Y; Wang S; Yin X; Xiang J; Li X; He M; Zhang X; Wu T; Xu P; Guo H
Cancer Gene Ther; 2017 Jan; 24(1):20-27. PubMed ID: 27982019
[TBL] [Abstract][Full Text] [Related]
54. Highly prevalent BRAF V600E and low-frequency TERT promoter mutations underlie papillary thyroid carcinoma in Koreans.
Kim SY; Kim T; Kim K; Bae JS; Kim JS; Jung CK
J Pathol Transl Med; 2020 Jul; 54(4):310-317. PubMed ID: 32527075
[TBL] [Abstract][Full Text] [Related]
55. Telomerase reverse transcriptase promoter mutations in bladder cancer: high frequency across stages, detection in urine, and lack of association with outcome.
Allory Y; Beukers W; Sagrera A; Flández M; Marqués M; Márquez M; van der Keur KA; Dyrskjot L; Lurkin I; Vermeij M; Carrato A; Lloreta J; Lorente JA; Carrillo-de Santa Pau E; Masius RG; Kogevinas M; Steyerberg EW; van Tilborg AA; Abas C; Orntoft TF; Zuiverloon TC; Malats N; Zwarthoff EC; Real FX
Eur Urol; 2014 Feb; 65(2):360-6. PubMed ID: 24018021
[TBL] [Abstract][Full Text] [Related]
56. Telomerase reverse transcriptase (TERT) promoter mutation analysis of benign, malignant and reactive urothelial lesions reveals a subpopulation of inverted papilloma with immortalizing genetic change.
Cheng L; Davidson DD; Wang M; Lopez-Beltran A; Montironi R; Wang L; Tan PH; MacLennan GT; Williamson SR; Zhang S
Histopathology; 2016 Jul; 69(1):107-13. PubMed ID: 26679899
[TBL] [Abstract][Full Text] [Related]
57. TERT promoter mutation as an early genetic event activating telomerase in follicular thyroid adenoma (FTA) and atypical FTA.
Wang N; Liu T; Sofiadis A; Juhlin CC; Zedenius J; Höög A; Larsson C; Xu D
Cancer; 2014 Oct; 120(19):2965-79. PubMed ID: 24898513
[TBL] [Abstract][Full Text] [Related]
58. Association of telomerase reverse transcriptase promoter mutations with clinicopathological features and prognosis of thyroid cancer: a meta-analysis.
Su X; Jiang X; Wang W; Wang H; Xu X; Lin A; Teng X; Wu H; Teng L
Onco Targets Ther; 2016; 9():6965-6976. PubMed ID: 27956840
[TBL] [Abstract][Full Text] [Related]
59. Recurrent TERT promoter mutations in urothelial carcinoma and potential clinical applications.
Kurtis B; Zhuge J; Ojaimi C; Ye F; Cai D; Zhang D; Fallon JT; Zhong M
Ann Diagn Pathol; 2016 Apr; 21():7-11. PubMed ID: 27040924
[TBL] [Abstract][Full Text] [Related]
60. Association of genetic polymorphisms in the telomerase reverse transcriptase gene with prostate cancer aggressiveness.
Wu D; Yu H; Sun J; Qi J; Liu Q; Li R; Zheng SL; Xu J; Kang J
Mol Med Rep; 2015 Jul; 12(1):489-97. PubMed ID: 25738283
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
